|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.2 TWD | -0.36% |
|
+0.91% | -20.35% |
| Mar. 20 | CHO Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | CHO Pharma, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
CHO Pharma, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 3.57 million compared to TWD 0.138 million a year ago. Net loss was TWD 205.93 million compared to TWD 296.84 million a year ago.
Basic loss per share from continuing operations was TWD 1.12 compared to TWD 1.62 a year ago. Diluted loss per share from continuing operations was TWD 1.12 compared to TWD 1.62 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.35% | 362M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
CHO PHARMA, INC. 
